At ToxGenSolutions BV (TGS), our mission is to revolutionize how we detect and manage debilitating diseases like Alzheimer's. We believe in the power of early diagnostic tools to change the course of health outcomes. Our microRNA diagnostics identify Alzheimer's up to at least six years before symptoms manifest, offering a significant window for intervention that could reduce both the human and economic impacts documented in recent studies. Through our technology, we're not just advancing research; we're providing real-world solutions that can alleviate the immense burden of this disease. This technology is also a game changer for pharmaceutical companies. It allows them to clearly identify which participants in their studies are at risk of developing Alzheimer's within the next six years and which are not. This clear distinction improves the design and accuracy of clinical trials, paving the way for the development of new treatments that can be applied before the disease affects patients. Our work is not just about diagnosing earlier; it’s about enabling smarter, faster development of therapies that could potentially prevent the disease altogether. “Declare the past, diagnose the present, foretell the future.” ― Hippocrates If you're interested in exploring partnership opportunities or want early access to our technology, please reach out to us at [email protected]. #ToxGenSolutions #EarlyDetection #AlzheimersResearch #AD #HealthTech #ClinicalTrials #Innovation #Diagnostics #Pharma #Biotechnology
ToxGenSolutions BV (TGS)
Biotechnologisch onderzoek
Maastricht, Limburg 888 volgers
Epigenetics-based diagnostics, prognostics and preventative therapeutics for high-impact chronic pathologies.
Over ons
ToxGenSolutions (TGS) applies toxicogenomic approaches on human health problems to provide the customer with epigenetic biomarker fingerprints for application in novel, more accurate, methods for the particular diagnosis of their need. TGS aims to develop novel and innovative epigenetic profiles hallmarking high-impact chronic and rare neurodevelopmental diseases to serve as early, preclinical, diagnostic verdicts of a disease. With the development of these novel tools, TGS aims to bridge the frequently large gap towards disease progression and therapeutic intervention. TGS provides novel epigenetic diagnostic methods for the early identification of pressing high-impact pathologies including cancer, neurodegeneration and immune-dysfunction, before irreversible disease-specific alterations in patient physiology have occurred. By doing this, we aim to provide an optimal perspective for patient healthcare as well as follow-up programs and preventative therapeutic interventions.
- Website
-
https://toxgen.solutions
Externe link voor ToxGenSolutions BV (TGS)
- Branche
- Biotechnologisch onderzoek
- Bedrijfsgrootte
- 11 - 50 medewerkers
- Hoofdkantoor
- Maastricht, Limburg
- Type
- Particuliere onderneming
- Opgericht
- 2015
- Specialismen
- diagnostics, Therapeutics en Neuroscience
Locaties
-
Primair
Oxfordlaan 70
Maastricht, Limburg 6229 EV, NL
Medewerkers van ToxGenSolutions BV (TGS)
-
Maria Tsamou
Scientific Researcher at ToxGenSolutions BV (TGS)
-
Melinda Szegedi
Biomed student at UM | Poiesy | ToxGenSolutions | Immunometabolism CARIM Institute
-
Keano Achilleas Samaritakis
Chief Computational Officer at ToxGenSolutions // Epidemiologist and Biomedical Engineer
-
Fabiënne Kremers
Biomedical Engineer at ToxGenSolutions
Updates
-
ToxGenSolutions BV (TGS) heeft dit gerepost
What are #HealthTransformers like Erwin L Roggen, PhD, of ToxGenSolutions BV (TGS) saying about our #HealthMoonshot Communities? Check out hundreds of #testimonials & join us! ➡️ https://lnkd.in/gemwhQqi
-
-
ToxGenSolutions BV (TGS) heeft dit gerepost
Thanks to Damian Toczydłowski for highlighting this review. The role of noncoding RNAs in human evolution and therapeutic innovation is truly fascinating and promises exciting new advancements in the field. A must-read for those interested in RNA-based therapies I would say. MicroRNAs are not only key in therapeutic developments but also play an important role in early diagnostics for Alzheimer’s disease. We at ToxGenSolutions BV (TGS) can detect Alzheimer’s up to 6 years before symptoms appear using a patent-pending microRNA panel, offering a real advantage in early intervention. #microRNA #RNA #therapeutics #diagnostics #toxgensolutions
Breaking 𝐓𝐡𝐞 𝐂𝐨𝐝𝐞 𝐨𝐟 𝐋𝐢𝐟𝐞 via 𝐄𝐩𝐢𝐠𝐞𝐧𝐨𝐦𝐢𝐜𝐬 & 𝐅𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 ★ Pioneering The Future of 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 ★ Scientist—𝐄𝐩𝐢𝐠𝐞𝐧𝐞𝐭𝐢𝐜𝐢𝐬𝐭
𝐄𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐭𝐨𝐠𝐞𝐭𝐡𝐞𝐫: 𝐃𝐨𝐞𝐬 𝐭𝐡𝐞 𝐫𝐨𝐥𝐞 𝐨𝐟 𝐧𝐨𝐧𝐜𝐨𝐝𝐢𝐧𝐠 𝐑𝐍𝐀𝐬 𝐢𝐧 𝐡𝐮𝐦𝐚𝐧 𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐜𝐡𝐚𝐧𝐠𝐞 𝐭𝐡𝐞 𝐰𝐚𝐲 𝐰𝐞 𝐭𝐡𝐢𝐧𝐤 𝐚𝐛𝐨𝐮𝐭 𝐧𝐞𝐰 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐝𝐞𝐬𝐢𝐠𝐧𝐬? I've stumbled upon an incredibly inspiring read. The recent review from "Trends in Molecular Medicine" elaborates on the intriguing world of noncoding RNAs (ncRNAs) & their crucial role in human evolution, as well as their impact on our health & diseases. It actually covers different classes of ncRNAs, such as microRNAs, long noncoding RNAs, & circular RNAs. Further, it explains how each class helps regulate gene expression & supports various developmental processes. The authors emphasize that ncRNAs have evolved alongside us, shaping our unique traits & adaptations over time. This isn't straightforward. Some molecules are highly conserved & remain largely unchanged even after thousands of years. They also explore new therapeutic approaches targeting ncRNAs, suggesting these could hold great promise for gene therapy space & personalized medicine. But don’t assume this is another dry commentary full of boring & irrelevant theories. It's actually rather translational. This can be quite inspirational, especially if you're working in RNA-based therapy development. Overall, the review encourages more research to understand the complex roles of ncRNAs in different biological contexts. As you might have noticed, RNA therapies are making BIG waves in the pharmaceutical world. We're on the verge of seeing new RNA-based therapeutics & vaccines for cancer & autoimmune diseases. But that’s not all—these therapies could also provide solutions for rare diseases. Exciting times are ahead, so stay tuned! It's not just a golden era. We can say we're entering an RNAissance! ~~~ Thank you so much for reading. Wish to learn more? Hit the 𝐅𝐨𝐥𝐥𝐨𝐰 [👥👋🏼]—you'll never miss out on the latest 𝐄𝐩𝐢𝐠𝐞𝐧𝐞𝐭𝐢𝐜 news 🎯! Give it a like [👍🏼] or share [🕊️] the post to spread this Epi-message 💌. I'm 𝐃𝐚𝐦𝐢𝐚𝐧, & I talk about: #precisionmedicine #epigenetics #genomics #singlecell #genetics #science #health —Always be on top of your DNA!
-
-
ToxGenSolutions BV (TGS) heeft dit gerepost
The 2024 update to the standing Lancet Commission on dementia prevention, intervention, and care adds two new risk factors (high LDL cholesterol and vision loss) and indicates that nearly half of all dementia cases worldwide could be prevented or delayed by addressing 14 modifiable risk factors.
-
📢 Vacancy Alert: Scientific Machine Learning Engineer (Postdoc) Come work with us at ToxGenSolutions, a molecular diagnostics company in Maastricht, Netherlands. We are looking for a highly motivated and independent Postdoctoral Researcher to join our team. 🧬 If you have a Ph.D. in a related field (epidemiology, bioinformatics, biostatistics, applied mathematics, etc.), strong machine learning skills, and a passion for innovative research in diagnostics, apply now! 📅 Apply by August 16th, 2024 📧 Send your application via Magnet Me
Scientific Machine Learning Engineer (Postdoc) in Maastricht bij ToxGenSolutions | Magnet.me
magnet.me
-
ToxGenSolutions BV (TGS) heeft dit gerepost
𝗧𝗼𝘅𝗚𝗲𝗻𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝘀𝗹𝘂𝗶𝘁 𝘇𝗶𝗰𝗵 𝗮𝗮𝗻 𝗯𝗶𝗷 𝗦𝘁𝗮𝗿𝘁𝗨𝗽 𝗛𝗲𝗮𝗹𝘁𝗵'𝘀 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿 𝗠𝗼𝗼𝗻𝘀𝗵𝗼𝘁 🇳🇱 Deze samenwerking is erop gericht om de opsporing van de ziekte van Alzheimer nieuw leven in te blazen door middel van de eersteklas testservice van ToxGenSolutions BV (TGS), die een prognose biedt voor personen met een hoog risico tot 4-6 jaar voordat de eerste symptomen kunnen worden gedetecteerd. 🌍 This collaboration aims to bring new life to Alzheimer’s disease detection through ToxGenSolutions BV (TGS)'s first-in-class testing service, which provides a prognosis for high-risk individuals up to 4-6 years before the first symptoms can be detected. https://lnkd.in/e6-WfTgp
ToxGenSolutions sluit zich aan bij StartUp Health's Alzheimer Moonshot
brightlands.com
-
PRESS RELEASE 🗞️ ToxGenSolutions joins StartUp Health’s Alzheimer's Moonshot to revolutionize early detection with a groundbreaking 4-6 year advance window. For more information, please find the full press release attached. 🧠🚀
-
ToxGenSolutions BV (TGS) heeft dit gerepost
Game-changing news from the world of #Alzheimers research! ToxGenSolutions, a new StartUp Health company, has developed a microRNA-based test for early detection of Alzheimer's. This could revolutionize diagnosis and treatment timelines. #AlzMoonshot #HealthTransformer #HealthMoonshot Meet Erwin L Roggen, PhD, and Maria Tsamou, PhD, of ToxGenSolutions BV (TGS) ⤵️ https://ow.ly/N6lh50Sca36
ToxGenSolutions Zeroes in on microRNA for the Early Detection of Alzheimer’s — StartUp Health
startuphealth.com
-
ToxGenSolutions BV (TGS) heeft dit gerepost
Two of our esteemed customers are making waves in the health innovation space, and they're getting some well-deserved recognition in the Brightlands Maastricht Health Campus BV newsletter! Obviously we want to shine some more light on them: Dive into the first article featuring Avalanche Medical B.V. and their groundbreaking work on a durable cartilage mini-prosthesis: https://shorturl.at/oSYUA Second article highlights ToxGenSolutions BV (TGS) and their cutting edge diagnostic technology. They're predicting Alzheimer's six years before the first symptoms appear! (Dutch readers, this one's for you): https://shorturl.at/ZadAm Let's show them some love and support for their incredible contributions to healthcare innovation! 💪 #HealthTech #InnovationSpotlight #LeadingTheChange
-
-
Our CEO, Erwin L. Roggen, will be representing us at the International Conference on Neurology and Brain Disorders in Baltimore this October. The integration of AI and computational approaches is revolutionizing diagnostics and therapeutics in neurology, opening new avenues for promoting healthier aging. Interested in learning more about our innovative work? Connect with Erwin in Baltimore! #neurology #alzheimersdisease #epigenetics #ToxGenSolutions #ai #computational #diagnostics #therapeutics
I am the Asst. Henry Walter, Conference manager INBC 2024 (Hybrid Event). October 21-23, 2024 - Baltimore, Maryland, USA WhatsApp: 1 540 709 1879
We are honored to welcome Erwin L J Roggen from ToxGenSolutions BV (TGS) to speak at our International Conference on Neurology and Brain Disorders hosted by Magnus Group in Baltimore! Join us to learn from one of the best in the field. 🗓️ October 21-23, 2024 📲 1 (540) 709-1879 🔗 neurologycongress.com #NeurologyConferences2024 #NeuroscienceConferences #BrainDisordersConference2024 #BrainCongress2024 #NeurologyEvents2024
-